The Claim
In postmenopausal women with osteopenia receiving adequate calcium and vitamin D, vitamin MK-7 supplementation has no significant effect on bone turnover markers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In postmenopausal women with low bone density who are already getting enough calcium and vitamin D, taking vitamin MK-7 does not change the rate of bone remodeling as measured by bone turnover markers.
See the scientific wording
In postmenopausal women with osteopenia receiving adequate calcium and vitamin D, vitamin MK-7 supplementation does not reduce bone turnover markers, indicating no significant effect on the rate of bone remodeling.
Vitamin MK-7 helps activate a bone protein called osteocalcin by adding a chemical group to it, which lets the protein bind better to bone mineral. This activation happens, but it does not change how fast bone is broken down or rebuilt, even when the body has enough calcium and vitamin D.
What the research says
1 studyEven though vitamin MK-7 helped a blood marker related to bone health, it didn’t make bones break down or rebuild any faster in women who were already getting enough calcium and vitamin D. So, it didn’t change the overall bone remodeling process.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.